HighTower Advisors
GH icon

HighTower Advisors’s Guardant Health GH Stock Holding History

HighTower Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,500
Closed -$80K – 3279
2021
Q2 		$80K Buy
+4,500
New +$605K ﹤0.01% 2842
2021
Q1 		– Sell
-169
Closed -$438K – 3132
2020
Q4 		$438K Buy
+169
New +$19.4K ﹤0.01% 1697

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors's GH Position: Q1 2026 in Review

HighTower Advisors reduced its Guardant Health (GH) stake by 17% in Q1 2026, selling an estimated $495K and leaving 23,446 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1670.

HighTower Advisors first reported a position in GH in Q2 2019 and has held it in 28 quarters since. The position peaked at $10.5M in Q1 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • HighTower Advisors held 23,446 shares of Guardant Health worth $2.17M as of Q1 2026.
  • HighTower Advisors sold 4,930 Guardant Health shares in Q1 2026, an estimated $495K.
  • Guardant Health made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #1670 holding.
  • HighTower Advisors first reported a position in Guardant Health in Q2 2019 and has held it in 28 quarters since.
  • HighTower Advisors's Guardant Health position peaked at $10.5M in Q1 2021.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.